COVID-19 vaccination in Zimbabwe

Last updated

COVID-19 vaccination in Zimbabwe
Date22 February 2021-present
LocationZimbabwe
Cause COVID-19 pandemic
Organised by Ministry of Health and Child Care (Zimbabwe)
Participants
  • 3,737,463 first doses [1]
  • 2,774,929 second doses [1]
Outcome24.50% of the Zimbabwean population received at least one dose [2]

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. [3] [4] As of 25 November 2021, 3,737,463 people have received their first dose, and 2,774,929 people have received their second dose. [1]

Contents

Corruption is alleged to exist within the public vaccination program, with priority for receiving vaccines being given to those willing to pay bribes to hospital staff, and members of Zimbabwe's ruling party ZANU-PF. Vaccines are reportedly available within the private health care system at a cost of approximately $40 USD. [5]

Vaccine in order

VaccineApprovalDeployment
Sinopharm BIBP Green check.svg YesGreen check.svg Yes
Covaxin Green check.svg YesDark Red x.svg No
Sinovac Green check.svg YesDark Red x.svg No
Sputnik V Green check.svg YesDark Red x.svg No

History

Timeline

On 14 February 2021, the first 200,000 doses of the Sinopharm BIBP vaccine landed at Harare's Robert Mugabe International Airport. [6] [7]

On 22 February 2021 Zimbabwe began its vaccination program. [8]

On 25 February the number of people vaccinated surpassed 10,000 people. [9]

In mid-June 2021, Alrosa Zim donated 25,000 doses of the Sputnik V COVID-19 vaccine to Zimbabwe, followed by 25,000 more doses a month later. [10]

On 8 July 2021, Zimbabwe received 2 million doses of the Sinopharm BIBP vaccine. [11]

By the end of March 2021, 85,866 vaccine doses had been administered; 433,939 by the end of April; one million by the end of May; 1.3 million by the end of June; 2.3 million by the end of July; 3.8 million by the end of August; 5.2 million by the end of September; 5.8 million by the end of October 2021. 42% of the target population had been fully vaccinated by the end of October.

Progress

There were 0.8 million fully vaccinated by the end of July 2021; 1.6 million by the end of August; 2.3 million by the end of September 2021.

Related Research Articles

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.

Sinopharm (company) Chinese state-owned enterprise

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine, Shanghai Shyndec Pharmaceutical, and Beijing Tiantan Biological Products.

COVID-19 pandemic in Zimbabwe Ongoing COVID-19 viral pandemic in Zimbabwe

The COVID-19 pandemic in Zimbabwe is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 .The COVID-19 pandemic was confirmed to have reached Zimbabwe in March 2020. Some of Zimbabwe's provinces, especially Manicaland, Masvingo and Mashonaland East, also struggled with a malaria outbreak at the same time. Though malaria is treatable, the healthcare system faces drug shortages and increased strain with the spread of COVID-19.

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks fifth in the world and second in Asia.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Nepal Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Comoros is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. 1 2 3 Ministry of Health and Child Care [@MoHCCZim] (25 November 2021). "COVID-19 update: As at 25 November 2021, Zimbabwe had 133 774 confirmed cases, including 128 540 recoveries and 4 704 deaths. To date, a total of 3 737 463 people have been vaccinated against COVID-19" (Tweet). Retrieved 25 November 2021 via Twitter.
  2. Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; MacDonald, Bobbie; Beltekian, Diana; Roser, Max (5 March 2020). "Coronavirus (COVID-19) Vaccinations". Our World in Data. Retrieved 14 April 2021.
  3. "Zimbabwe starts Covid-19 vaccinations, Vice President Chiwenga gets first shot". News24. Retrieved 5 March 2021.
  4. "Zimbabwe expected to begin COVID-19 vaccinations on Thursday". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 17 February 2021. Retrieved 5 March 2021.
  5. York, Geoffrey (5 August 2021). "Mounting desperation in Africa as COVID-19 vaccine shortage persists". The Globe and Mail. Harare and Johannesburg. Retrieved 5 August 2021.
  6. "WATCH: Zimbabweans react to Sinopharm COVID-19 vaccine | eNCA". www.enca.com. Retrieved 5 March 2021.
  7. News, Eyewitness. "First 200,000 coronavirus vaccines en route to Zimbabwe". ewn.co.za. Retrieved 5 March 2021.
  8. "Zimbabwe begins vaccine rollout with Sinopharm jabs | eNCA". www.enca.com. Retrieved 5 March 2021.
  9. @MoHCCZim (25 February 2021). "COVID-19 update: As at 25 February 2021, Zimbabwe had 35 994 confirmed cases, including 32 455 recoveries and 1 458 deaths" (Tweet). Retrieved 14 April 2021 via Twitter.
  10. "25 000 more doses arrive from Russia". The Herald. 15 July 2021. Retrieved 15 July 2021.
  11. "Zimbabwe gets 2 million Sinovac doses to boost Covid-19 vaccination". News24. Retrieved 9 July 2021.